These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30099430)

  • 1. [Practical aspects of the use of botulinum toxin in the treatment of idiopathic overactive bladder].
    Szczypior M; Matuszewski M
    Wiad Lek; 2018; 71(4):888-892. PubMed ID: 30099430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management].
    Hermieu JF; Ballanger P; Amarenco G; Chartier-Kastler E; Cosson M; Costa P; Fatton B; Deffieux X; Denys P; Gamé X; Haab F; Karsenty G; Le Normand L; Ruffion A; Saussine C
    Prog Urol; 2013 Dec; 23(17):1457-63. PubMed ID: 24286546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin for overactive bladder].
    Ziegelmüller BK; Sommer A; Bauer RM
    Urologe A; 2020 Aug; 59(8):963-972. PubMed ID: 32691107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature.
    Anger JT; Weinberg A; Suttorp MJ; Litwin MS; Shekelle PG
    J Urol; 2010 Jun; 183(6):2258-64. PubMed ID: 20400142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of overactive bladder with botulinum toxin type A (BTX-A).
    Grishin A; Spaska A; Kayumova L
    Toxicon; 2021 Sep; 200():96-101. PubMed ID: 34274378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder.
    Ellsworth P; Travis M
    Urol Nurs; 2014; 34(4):165-71. PubMed ID: 25233617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin in male lower urinary tract symptoms (LUTS): What can we expect?].
    Schönburg S
    Urologie; 2024 Jul; 63(7):653-657. PubMed ID: 38698262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome].
    Deffieux X; Fatton B; Denys P; Chartier-Kastler E; Amarenco G; Haab F; Costa P; Game X; Karsenty G; Saussine C; Ballanger P; Le Normand L; Ruffion A; Hermieu JF; Cosson M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):572-80. PubMed ID: 25087018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
    Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
    World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin and refractory non-neurogenic overactive detrusor.
    Ksibi I; Godard AL; Azouvi P; Denys P; Dziri C
    Ann Phys Rehabil Med; 2009 Nov; 52(9):668-83. PubMed ID: 19729357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [INJECTION OF BOTULINUM TOXIN TYPE A IN THE BLADDER DETRUSOR AND SUBMUCOSA IN PATIENTS WITH OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Tur EI; Efremov NS
    Urologiia; 2015; (2):31-4. PubMed ID: 26237802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity.
    Patel AK; Patterson JM; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):27-32. PubMed ID: 17169008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure.
    Karsenty G; Baverstock R; Carlson K; Diaz DC; Cruz F; Dmochowski R; Fulford S; Giannantoni A; Heesakkers J; Kaufmann A; Peyrat L; Thavaseelan J; Dasgupta P
    Int J Clin Pract; 2014 Jun; 68(6):731-42. PubMed ID: 24472109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
    Kulaksizoglu H; Parman Y
    Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromodulation as a treatment for overactive bladder syndrome].
    Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
    Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.
    Chuang YC; Kaufmann JH; Chancellor DD; Chancellor MB; Kuo HC
    J Urol; 2014 Dec; 192(6):1743-9. PubMed ID: 25046622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.